

Is Agrylin still in shortage in 2026? Get the latest update on Anagrelide availability, pricing, and what patients can do to find it in stock.
If you take Agrylin (Anagrelide) for essential thrombocythemia or another myeloproliferative neoplasm, staying on top of shortage news isn't just helpful — it's essential for your health. Going without this platelet-reducing medication can lead to dangerous spikes in platelet counts and serious complications.
In this article, we'll give you the most current information about Agrylin availability in 2026, explain why shortages happen, and outline exactly what you can do to make sure you don't miss a dose.
Anagrelide — the generic name for Agrylin — experienced a notable shortage in 2018-2019 that affected both the brand-name and generic versions of the medication. That shortage was resolved when Teva Pharmaceuticals restored its supply of generic Anagrelide capsules in early 2019.
As of early 2026, there is no formal nationwide shortage of Anagrelide listed by the FDA. However, that doesn't mean the medication is easy to find everywhere. Patients across the country continue to report sporadic availability issues, particularly at large chain pharmacies that don't regularly stock specialty medications.
The reality is that "not in shortage" and "easy to find" are two very different things when it comes to niche medications like Agrylin.
Several factors contribute to ongoing availability challenges, even when there's no official shortage:
Brand-name Agrylin is manufactured exclusively by Takeda Pharmaceuticals. Generic Anagrelide is produced by a small number of manufacturers, including Teva. With so few suppliers, any production hiccup — maintenance shutdowns, raw material delays, quality control issues — can create noticeable supply gaps.
Most retail pharmacies stock medications based on local demand. Because Agrylin is prescribed primarily by hematologists and oncologists for a relatively uncommon condition, many pharmacies don't keep it on their shelves. This means even when the national supply is adequate, your local pharmacy may not have it.
Some insurance plans direct patients to specific pharmacies — often mail-order or specialty pharmacies — for specialty medications. This can concentrate demand at certain distribution points while leaving retail pharmacies without stock. Regional distribution patterns can also create pockets of scarcity even when overall supply is sufficient.
The generic Anagrelide market is small enough that manufacturers may not prioritize production increases. If one manufacturer experiences a disruption, the remaining suppliers may not be able to ramp up quickly enough to fill the gap.
Cost is a major concern for patients, especially those dealing with availability issues who may need to fill their prescription at a pharmacy that doesn't accept their usual discount programs.
If cost is a barrier, check out our detailed guide on how to save money on Agrylin in 2026.
The treatment landscape for essential thrombocythemia is evolving, which may indirectly help with Agrylin availability by giving patients and doctors more options:
For a full discussion of treatment alternatives, see our article on alternatives to Agrylin.
If you're having trouble finding Agrylin today, here are the most effective steps:
Medfinder helps you find pharmacies near you that have Agrylin or generic Anagrelide in stock. It's the fastest way to check availability without making dozens of phone calls.
Don't limit yourself to your usual pharmacy. Try:
If your prescription is written for brand-name Agrylin, ask your doctor or pharmacist about switching to generic Anagrelide. The generic is therapeutically equivalent and much more widely available — plus it costs a fraction of the brand price.
Request refills at least 7-10 days before you run out. If your pharmacy needs to order it, this gives them time to receive the shipment before you miss a dose.
If you anticipate ongoing difficulty finding Agrylin, discuss a contingency plan with your hematologist. This might include:
For more detailed strategies, read our guide on how to find Agrylin in stock near you.
If you're completely out of Agrylin and can't find it anywhere:
While Agrylin isn't in a formal shortage as of 2026, the practical reality for many patients is that it's still difficult to find at their local pharmacy. Understanding why this happens — and having a plan in place — is the best way to protect yourself.
Use Medfinder to search for stock, keep your doctor informed, refill early, and never hesitate to ask for help. Your health depends on consistent access to this medication, and you have more resources than you might think.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.